HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.

Abstract
With the consideration of the multifactorial etiology of diabetic peripheral neuropathy, an ideal drug or drug combination should target at least several key pathogenetic mechanisms. The flavonoid baicalein (5,6,7-trihydroxyflavone) has been reported to counteract sorbitol accumulation, activation of 12/15-lipoxygenase, oxidative-nitrosative stress, inflammation, and impaired signaling in models of chronic disease. This study evaluated baicalein on diabetic peripheral neuropathy. Control and streptozotocin-diabetic C57Bl6/J mice were maintained with or without baicalein treatment (30 mg kg(-1) d(-1), i.p., for 4 weeks after 12 weeks without treatment). Neuropathy was evaluated by sciatic motor and hind-limb digital sensory nerve conduction velocities, thermal algesia (Hargreaves test), tactile response threshold (flexible von Frey filament test), and intraepidermal nerve fiber density (fluorescent immunohistochemistry with confocal microscopy). Sciatic nerve and spinal cord 12/15-lipoxygenase and total and phosphorylated p38 mitogen-activated protein kinase expression and nitrated protein levels were evaluated by Western blot analysis, 12(S)hydroxyeicosatetraenoic acid concentration (a measure of 12/15-lipoxygenase activity) by ELISA, and glucose and sorbitol pathway intermediate concentrations by enzymatic spectrofluorometric assays. Baicalein did not affect diabetic hyperglycemia, and alleviated nerve conduction deficit and small sensory nerve fiber dysfunction, but not intraepidermal nerve fiber loss. It counteracted diabetes-associated p38 mitogen-activated protein kinase phosphorylation, oxidative-nitrosative stress, and 12/15-lipoxygenase overexpression and activation, but not glucose or sorbitol pathway intermediate accumulation. In conclusion, baicalein targets several mechanisms implicated in diabetic peripheral neuropathy. The findings provide rationale for studying hydroxyflavones with an improved pharmacological profile as potential treatments for diabetic neuropathy and other diabetic complications.
AuthorsRoman Stavniichuk, Viktor R Drel, Hanna Shevalye, Yury Maksimchyk, Tamara M Kuchmerovska, Jerry L Nadler, Irina G Obrosova
JournalExperimental neurology (Exp Neurol) Vol. 230 Issue 1 Pg. 106-13 (Jul 2011) ISSN: 1090-2430 [Electronic] United States
PMID21515260 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • 12-15-lipoxygenase
  • 12-hydroxyeicosatetraenoic acid receptor
  • Antioxidants
  • Blood Glucose
  • Flavanones
  • Oligonucleotides, Antisense
  • Receptors, Eicosanoid
  • 3-nitrotyrosine
  • Tyrosine
  • baicalein
  • Arachidonate 12-Lipoxygenase
  • Arachidonate 15-Lipoxygenase
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Antioxidants (therapeutic use)
  • Arachidonate 12-Lipoxygenase (metabolism)
  • Arachidonate 15-Lipoxygenase (metabolism)
  • Blood Glucose (drug effects, metabolism)
  • Body Weight (drug effects)
  • Diabetes Mellitus, Experimental (complications)
  • Diabetic Neuropathies (drug therapy, etiology, metabolism)
  • Disease Models, Animal
  • Flavanones (therapeutic use)
  • Gene Expression Regulation (drug effects)
  • Hyperalgesia (drug therapy)
  • Mice
  • Mice, Inbred C57BL
  • Neural Conduction (drug effects)
  • Oligonucleotides, Antisense (therapeutic use)
  • Oxidative Stress (drug effects)
  • Reaction Time (drug effects)
  • Receptors, Eicosanoid (metabolism)
  • Sciatic Nerve (metabolism)
  • Spinal Cord (metabolism)
  • Statistics, Nonparametric
  • Tyrosine (analogs & derivatives, metabolism)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: